Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis

BACKGROUND: Varenicline is probably the most effective smoking cessation pharmacotherapy, but is less widely used than nicotine replacement therapy. We therefore set out to identify the characteristics of numerically important groups of patients who typically do, or do not, receive varenicline in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yue, Lewis, Sarah, Britton, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192758/
https://www.ncbi.nlm.nih.gov/pubmed/25273646
http://dx.doi.org/10.1186/1471-2458-14-1024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192758/
https://www.ncbi.nlm.nih.gov/pubmed/25273646
http://dx.doi.org/10.1186/1471-2458-14-1024

Ejemplares similares